AARD - Aardvark Therapeutics, Inc. Common Stock
Aardvark Therapeutics, Inc. Common Stock Logo

AARD - Aardvark Therapeutics, Inc. Common Stock

https://aardvarktherapeutics.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. The company is headquartered in San Diego, California.

52W High
$19.58
52W Low
$4.88
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
N/A
Valuation
As of 2024-09-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
N/A
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
24.03%
Institutions (25–75% balanced)
24.90%
Shares Outstanding
21,384,400
Float
18,389,500
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2024-09-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-0.65
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.9912
Previous
-1.0950
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025